RCMI Coordinating Center (RCMI CC) Header Logo

Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk.

Phelps DL, Ward RM, Williams RL, Watterberg KL, Laptook AR, Wrage LA, Nolen TL, Fennell TR, Ehrenkranz RA, Poindexter BB, Michael Cotten C, Hallman MK, Frantz ID, Faix RG, Zaterka-Baxter KM, Das A, Bethany Ball M, Michael O'Shea T, Backstrom Lacy C, Walsh MC, Shankaran S, S?nchez PJ, Bell EF, Higgins RD. Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk. Pediatr Res. 2013 Dec; 74(6):721-9.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support